JCO Journals shared on LinkedIn:
“ASCO is pleased to name Thomas E. Stinchcombe, MD, FASCO as the new Editor-in-Chief of the Journal of Clinical Oncology (JCO)!
A long-standing leader in academic publishing and Fellow of ASCO, Dr. Stinchcombe brings years of dedication to JCO as a top peer reviewer and associate editor, alongside extensive clinical leadership across the National Clinical Trials Network and Duke Cancer Institute.
Dr. Stinchcombe’s vision is centered on maintaining rigorous peer-review standards, streamlining publication timelines, and expanding global reach, marking an exciting new chapter for the journal.
‘I am honored to lead JCO as Editor-in-Chief. My vision is to apply the lessons I have learned as associate editor to elevate studies that directly impact clinical care, streamline our publication timelines, and expand JCO’s geographic reach and reviewer pool across the globe.’
Join us in congratulating Dr. Stinchcombe, whose term begins January 1, 2027.”
Other articles featuring Thomas E. Stinchcombe on OncoDaily.